Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
BMJ
    January 2026

  1. Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial.
    BMJ. 2026;392:s43.
    >> Share

    December 2025
  2. PETRELLI F
    Adjuvant carboplatin for high risk triple negative breast cancer.
    BMJ. 2025;391:r2669.
    >> Share

  3. LIU Y, Gong Y, Zhu XZ, Liu GY, et al
    Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial.
    BMJ. 2025;391:e085457.
    >> Share

  4. NICKEL B, Ormiston-Smith N, Cvejic E, Isautier J, et al
    Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen.
    BMJ. 2025;391:e083649.
    >> Share

  5. DYER C
    Breast cancer failings: "Culture of complacency" led to unnecessary surgery and delayed treatment at NHS trust.
    BMJ. 2025;391:r2527.
    >> Share

    November 2025

  6. EXPRESSION OF CONCERN: First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study.
    BMJ. 2025;391:r2394.
    >> Share

    September 2025
  7. MA Z, He W, Zhang Y, Mao X, et al
    First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study.
    BMJ. 2025;390:e085029.
    >> Share

  8. XIA Y, Zhu Y, Ling L, Xu F, et al
    Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial.
    BMJ. 2025;390:e084290.
    >> Share

    August 2025
  9. SANCHEZ MJ, Petrova D
    Second primary cancers in breast cancer survivors.
    BMJ. 2025;390:r1798.
    >> Share

  10. BOWIE K
    Risk of second cancer after early breast cancer is low, study finds.
    BMJ. 2025;390:r1819.
    >> Share

  11. MACKENZIE M, Stobart H, Dodwell D, Taylor C, et al
    Patients need information on the risk of second cancer after early breast cancer.
    BMJ. 2025;390:r1584.
    >> Share

  12. MCGALE P, Dodwell D, Challenger A, Cutter D, et al
    Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.
    BMJ. 2025;390:e083975.
    >> Share

    July 2025
  13. RYSER MD, Thomas SM, Li Y, Lynch T, et al
    Cancer outcomes in women without upfront surgery for ductal carcinoma in situ: observational cohort study.
    BMJ. 2025;390:e083542.
    >> Share

    April 2025
  14. O'DOWD A
    NICE recommends "targeted" drug capivasertib for advanced breast cancer.
    BMJ. 2025;389:r762.
    >> Share

    December 2024
  15. PARK B, Chang Y, Ryu S, Tran TXM, et al
    Trajectories of breast density change over time and subsequent breast cancer risk: longitudinal study.
    BMJ. 2024;387:e079575.
    >> Share

  16. ROBINSON A
    Advances in breast cancer and bowel cancer treatments ... and other research.
    BMJ. 2024;387:q2699.
    >> Share

    October 2024
  17. HE M, Jiang YZ, Gong Y, Fan L, et al
    Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.
    BMJ. 2024;387:e079603.
    >> Share

  18. MASON S
    Risk prediction in early triple negative breast cancer.
    BMJ. 2024;387:q2088.
    >> Share

  19. TANNE JH
    Breast cancer: Cases rising among younger US women although deaths are dropping.
    BMJ. 2024;387:q2199.
    >> Share

    September 2024
  20. TANNE JH
    US women must be told breast density after mammogram, says FDA.
    BMJ. 2024;386:q2045.
    >> Share

  21. LEE SF, Kennedy SKF, Caini S, Wong HCY, et al
    Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis.
    BMJ. 2024;386:e079089.
    >> Share

    August 2024
  22. BAUM M
    Breast cancer screening does not improve length or quality of life.
    BMJ. 2024;386:q1752.
    >> Share

  23. AUTIER P
    Breast cancer screening expansion: modelling doesn't reflect real life and should not be used to update guidance.
    BMJ. 2024;386:q1750.
    >> Share

    July 2024
  24. RIMMER A
    Navigating breastfeeding through cancer treatment.
    BMJ. 2024;386:q1284.
    >> Share

    June 2024
  25. BELL KJ, Nickel B, Pathirana T, Blennerhassett M, et al
    Breast cancer screening from age 40 in the US.
    BMJ. 2024;385:q1353.
    >> Share

    May 2024
  26. TANNE JH
    US expert panel says breast cancer screening should begin at 40.
    BMJ. 2024;385:q1020.
    >> Share

    April 2024
  27. WISE J
    Breast cancer: Inaction on inequalities has led to unequal progress, say experts.
    BMJ. 2024;385:q854.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016